Aldomet and Neonatal disorder - a phase IV clinical study of FDA data

Summary:

Neonatal disorder is reported as a side effect among people who take Aldomet (methyldopa), especially for people who are male, 0-1 old, have been taking the drug for 1 - 6 months also take Viramune, and have Pre-eclampsia.

The phase IV clinical study analyzes which people have Neonatal disorder when taking Aldomet. It is created by eHealthMe based on reports of 2,289 people who have side effects when taking Aldomet from the FDA, and is updated regularly.

What is Aldomet?

Aldomet has active ingredients of methyldopa. It is often used in high blood pressure. eHealthMe is studying from 2,356 Aldomet users. Check the latest studies of Aldomet.

What is Neonatal disorder?

Neonatal disorder (disease of neonates) is found to be associated with 205 drugs and 340 conditions by eHealthMe. Check the latest studies of Neonatal disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

2,289 people reported to have side effects when taking Aldomet.
Among them, 15 people (0.66%) have Neonatal disorder.

Among these 15 people:

How long have people been on Aldomet when they have Neonatal disorder? *

What is the gender of people who have Neonatal disorder when taking Aldomet? *

female: 50 %
male: 50 %

What is the age of people who have Neonatal disorder when taking Aldomet? *

What are other drugs people take besides Aldomet? *

What are other side effects people have besides Neonatal disorder? *

Drug Exposure During Pregnancy: 6 people, 40.00%
Premature Baby: 6 people, 40.00%
Foetal Growth Retardation (a baby in the womb fails to grow at the expected rate during the pregnancy): 4 people, 26.67%
Complications Of Maternal Exposure To Therapeutic Drugs: 3 people, 20.00%
Hypoglycaemia Neonatal (deficiency of glucose in the bloodstream in neonatal): 3 people, 20.00%
Rashes (redness): 2 people, 13.33%
Cyanosis Neonatal (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails in newborn): 2 people, 13.33%
Deafness Neurosensory: 2 people, 13.33%
Jaundice Neonatal (yellowing of skin in neonate): 2 people, 13.33%
Bradycardia Neonatal (sinus rhythm with a heart rate below the normal limit in newborn): 2 people, 13.33%

What are the existing conditions these people have? *

Pre-Eclampsia (high blood pressure and significant amounts of protein in the urine of a pregnant woman): 2 people, 13.33%
Type 2 Diabetes: 1 person, 6.67%
Pregnancy Induced Hypertension: 1 person, 6.67%
Human Immunodeficiency Virus Transmission: 1 person, 6.67%
Hiv Infection: 1 person, 6.67%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 6.67%
Depression: 1 person, 6.67%
Conversion Disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Aldomet and have Neonatal disorder?

- Check whether Neonatal disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aldomet:

Aldomet (2,356 reports)

Browse all side effects of Aldomet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neonatal disorder:

Neonatal disorder (205 drugs)

Browse all the conditions that are associated with Neonatal disorder:

Neonatal disorder (340 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methyldopa (the active ingredients of Aldomet) and Aldomet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.